Therapy monitoringTumour evolution and the emergence of resistance to therapy – including chemotherapy, targeted therapy, immunotherapy and radiotherapy – impact on cancer patient outcomes. The development of technologies to monitor response to treatment in real-time, rather than relying on scans at predefined time points – typically at the end of a treatment plan – will help to understand when a patient has stopped responding to a treatment.

By actively measuring treatment response, clinicians will be able to change to another treatment as soon as they know the current one has stopped working. This will benefit patients as they will be offered the most appropriate treatment at the most appropriate time and reduce side effects from a treatment that wasn’t giving a health benefit.